Buy Trittico pills 150 mg 20 pcs
  • Buy Trittico pills 150 mg 20 pcs

Trittico® [Trazodone]

Aziende Kimike Riunite Angelini Francesco A.K.R.A.
580 Items
Dosage form
Brand & Manufacturer
Package Size
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Trittico is an antidepressant. Trazodone, being a derivative of triazolopyridine, has a predominantly antidepressant effect, with some sedative and anxiolytic effect. Trazodone does not affect MAO, which distinguishes it from MAO inhibitors, tricyclic antidepressants. The mechanism of action of trazodone is associated with a high affinity of the drug for some subtypes of serotonin receptors with which trazodone enters into antagonistic or agonistic interaction depending on the subtype, as well as with a specific ability to cause inhibition of serotonin reuptake.
Quickly affects mental (affective tension, irritability, fear, insomnia) and somatic anxiety symptoms (heartbeat, headache, muscle pain, frequent urination, sweating, hyperventilation). Trazodone is effective for sleep disorders in patients with depression, increases the depth and duration of sleep, restores its physiological structure and quality. Trittico stabilizes the emotional state, improves mood, reduces the pathological craving for alcohol in patients suffering from chronic alcoholism during the period of alcohol withdrawal syndrome, also in remission. With withdrawal symptoms in patients suffering from dependence on benzodiazepine derivatives, trazodone is effective in treating anxiety and depression and sleep disorders. During remission, benzodiazepines can be completely replaced by trazodone. It helps to restore libido and potency in both depressed patients and non-depressed individuals. The drug is not addictive. It has little effect on the neutral uptake of norepinephrine and dopamine. Does not affect body weight.


- Anxiety-depressive states of an endogenous nature (including involutional depression).
- Psychogenic depression (including reactive and neurotic depression).
- Anxiety-depressive conditions on the background of organic diseases of the central nervous system (dementia, Alzheimer's disease, atherosclerosis of cerebral vessels).
- Depressive states with prolonged pain syndrome.
- Alcoholic depression.
- Benzodiazepine addiction.
- Disorders of libido and potency.


1 tablet, controlled release, contains: trazodone hydrochloride 150 mg.
Excipients: sucrose, carnauba wax, povidone (polyvinylpyrrolidone), magnesium stearate.

No customer reviews for the moment.

Write your review

Write your review

Trittico® [Trazodone]

Dosage and Administration

The drug is taken orally 30 minutes before a meal or 2-4 hours after a meal. The prescribed dose of the pill should be taken whole, without chewing and drinking plenty of water.
For adults prescribed in the initial dose of 100 mg 1 time / day after meals before bedtime. On the 4th day, you can increase the dose to 150 mg. In the future, in order to achieve the optimal therapeutic effect, the dose is increased by 50 mg / day every 3-4 days until the optimum dose is reached. The daily dose of more than 150 mg should be divided into 2 doses, with a lower dose taken after lunch, and the main dose at bedtime. The maximum daily dose for outpatients is 450 mg. The maximum daily dose for inpatients is 600 mg.
In the treatment of libido disorders The recommended daily dose is 50 mg.
In the treatment of impotencein the case of drug monotherapy, the recommended daily dose of more than 200 mg, with combination therapy - 50 mg.
In the treatment of benzodiazepine addiction The recommended treatment regimen is based on a gradual, sometimes over several months, reduction of the dose of benzodiazepine. Each time, reducing the dose of benzodiazepine by 1/4 or 1/2 tablet, 50 mg of trazodone are simultaneously added. This ratio is left unchanged for 3 weeks, then proceed to a further gradual reduction of the dose of benzodiazepines until their complete abolition. After that, the daily dose of trazodone is reduced by 50 mg every 3 weeks.
For elderly and debilitated patients initial dose - up to 100 mg / day in fractional doses or 1 time / day before bedtime. The dose may be increased under the supervision of a physician, depending on the effectiveness and tolerability of the drug. Usually do not require a dose in excess of 300 mg / day.
Children aged 6-18 years: The initial daily dose of 1.5-2 mg / kg / day, divided into several doses. If necessary, gradually increase the dose to 6 mg / kg / day with an interval of 3-4 days.

Adverse reactions

From the side of the central nervous system: fatigue, drowsiness, agitation, headache, dizziness, weakness, myalgia, discoordination, paresthesia, disorientation, tremor.
Since the cardiovascular system and blood (hematopoiesis, hemostasis): decrease in blood pressure, orthostatic hypotension due to adrenolytic action (especially in individuals with vasomotor lability), arrhythmia, conduction disturbance, bradycardia.
From the hemopoietic system: leukopenia and neutropenia (usually minor).
From the digestive system: dry and bitter mouth, nausea, vomiting, diarrhea, loss of appetite.
Other: allergic reactions, eye irritation, priapism (you should immediately stop taking the drug and consult a doctor).


- Pregnancy.
- Lactation period.
- Children's age up to 6 years.
- Hypersensitivity to the drug.
Precautions should be prescribed to patients with:
- AV blockade.
- Myocardial infarction (early recovery period).
- Arterial hypertension (may require correction of doses of antihypertensive drugs).
- Ventricular arrhythmia.
- Priapism in history.
- Renal and / or liver failure.
- As well as patients under the age of 18 years.

Drug interactions

Trazodone may enhance the effect of certain antihypertensive drugs and usually requires a reduction in their doses. The simultaneous appointment with drugs that depress the central nervous system (including clonidine, methyldopa), enhances the effect of the latter. Antihistamines and drugs with anticholinergic activity enhance the anticholinergic effect of trazodone.

Pregnancy and Lactation

The drug is contraindicated for use during pregnancy and lactation (breastfeeding).

Special instructions

Since the drug has some adrenolytic activity, the development of bradycardia and a decrease in blood pressure are possible. Therefore, it should be carefully prescribed the drug to patients with impaired cardiac conduction, AV-blockade of varying severity, in patients with recent myocardial infarction. When using trazodone, there may be some decrease in the number of leukocytes, which does not require specific treatment, except in cases of severe leukopenia. Therefore, during the period of treatment it is recommended to conduct studies of peripheral blood, especially in the presence of sore throat when swallowing and the appearance of fever.The drug does not have an anticholinergic effect, so it can be administered to elderly patients suffering from prostatic hypertrophy, angle-closure glaucoma, impaired cognitive functions.
With the appearance of long and inadequate erections, the patient should consult a doctor. During the period of treatment, the patient should refrain from drinking alcohol.
Use in pediatrics: there are no studies on the effectiveness of the drug in pediatrics, so the drug should be used with caution in children and adolescents under the age of 18 years. Doses for children under 6 years of age have not been established.
Influence on ability to drive motor transport and control mechanisms: since the drug has anxiolytic and sedative activity, a decrease in the ability to concentrate and the speed of psychomotor reactions is possible. During treatment, the patient should avoid practicing potentially hazardous activities, including driving vehicles and driving mechanisms.


Symptoms: nausea, drowsiness, hypotension, increased frequency and severity of side effects.
Treatment: There is no specific antidote to the drug. In cases of overdose, symptomatic treatment is carried out (including gastric lavage, forced diuresis).

  • Brand name: Trittico
  • Active ingredient: Trazodone
  • Dosage form: Controlled release pills
  • Manufacturer: Aziende Kimike Riunite Angelini Francesco A.K.R.A.
  • Country of Origin: Italy

Studies and clinical trials of Trazodone (Click to expand)
  1. Panic Management, Trazodone and a Combination of Both in the Treatment of Panic Disorder
  2. Trazodone in the treatment of behaviour in frontotemporal dementia
  3. The influence of trazodone treatment on cognitive functions in outpatients with major depressive disorder
  5. Exhibitionism and low-dose trazodone treatment
  6. Effect of Preferential Solvation on the Thermodynamic Properties of Antidepressant Drug Trazodone in Aqueous Ethanol: Linear Free-Energy Relationships
  7. Sleep apnea in olivopontocerebellar degeneration: Treatment with trazodone
  8. Structure-Activity Relationship Studies of CNS Agents, Part 22: A Search for New Trazodone-Like Antidepressants: Synthesis and Preliminary Receptor Binding Studies
  9. HPLC of trazodone in serum after microscale protein precipitation
  10. ChemInform Abstract: Synthesis and Biological Activity of 1-, 2- or 3-Substituted Benzothieno[2,3-d]triazole Derivatives Structurally Related to Trazodone.
  11. ChemInform Abstract: α1-Adrenoceptor Antagonists. Rational Design, Synthesis and Biological Evaluation of New Trazodone-Like Compounds.
  12. Pre- and postsynaptic α-adrenergic receptor effects of trazodone in the anesthetized dog
  13. A pilot placebo-controlled study of trazodone and buspirone in alzheimer's disease
  14. Crossover reaction between mianserin and trazodone for restless legs syndrome
  15. Org 3770 (mirtazapine) versus trazodone: A placebo controlled trial in depressed elderly patients
  16. Trazodone-induced cardiac arrhythmias: a report of two cases
  17. Synthesis and biological activity of 1-, 2- or 3-Substituted benzothieno-[2,3-d]triazole derivatives structurally related to trazodone
  18. Preparation of 14C- labelled trazodone hydrochloride
  19. Quantitative analysis of trazodone hydrochloride in tablets by an ion-selective electrode
  20. New hybrids of quipazine and trazodone as selective inhibitors of uptake of 5-hydroxytryptamine
  21. Voltammetric oxidation of trazodone
  22. Trazodone therapy of the post-stroke depression
  23. Synthesis and trazodone-like pharmacological profile of 1- and 2-[3-[4-(X)-1-piperazinyl]-propyl]-benzotriazoles
  24. Synthesis and biological activity of benzotriazole derivatives structurally related to trazodone

Customers who bought this product also bought:

8 other products in the same category: